Testing communication during implantation
    3.
    发明授权
    Testing communication during implantation 有权
    测量植入过程中的沟通

    公开(公告)号:US08983619B2

    公开(公告)日:2015-03-17

    申请号:US12732403

    申请日:2010-03-26

    Abstract: A system and method are described for testing communication through a patient during implantation using telemetry coupling electrodes on a delivery catheter. In one example, at least two telemetry coupling electrodes may be placed on or within a delivery catheter to test conductive communication with external body electrodes during implantation. In some instances, the telemetry coupling electrodes of the delivery catheter may approximate the spacing of telemetry electrodes on an IMD. In this manner, testing conductively coupled communication with telemetry coupling electrodes of the catheter may be used to mimic the telemetry electrodes on the IMD and determine a target position and/or orientation of an electrode or electrodes of the IMD for successful conductive communication through the body.

    Abstract translation: 描述了一种系统和方法,用于在植入期间通过患者使用传送导管上的遥测耦合电极来测试通信。 在一个示例中,至少两个遥测耦合电极可以放置在输送导管上或内部,以在植入期间测试与外部身体电极的导电连通。 在一些情况下,输送导管的遥测耦合电极可以接近IMD上遥测电极的间距。 以这种方式,测试与导管的遥测耦合电极的导电耦合通信可以用于模拟IMD上的遥测电极,并且确定IMD的电极或电极的目标位置和/或取向以便通过身体成功地导电连通 。

    Tissue oxygenation monitoring in heart failure
    5.
    发明授权
    Tissue oxygenation monitoring in heart failure 有权
    心力衰竭组织氧合监测

    公开(公告)号:US08571620B2

    公开(公告)日:2013-10-29

    申请号:US12797816

    申请日:2010-06-10

    CPC classification number: A61N1/36557

    Abstract: A medical device system and associated method are used for monitoring a heart failure patient. A medical device for monitoring delivery of a therapy includes a sensor sensing an optical sensor signal corresponding to light attenuation by a volume of body tissue of a patient, a therapy delivery module to deliver a therapy, and a processor configured to compute a first tissue oxygenation measurement from the optical sensor signal prior to initiating delivery of the therapy, compute a second tissue oxygenation measurement from the optical sensor signal subsequent to initiating delivery of the therapy, compare the first and the second tissue oxygenation measurements, and determine whether the delivered therapy was successful in response to the first tissue oxygenation measurement and the second tissue oxygenation measurement.

    Abstract translation: 医疗器械系统和相关方法用于监测心力衰竭患者。 用于监测治疗递送的医疗装置包括传感器,其感测对应于患者的身体组织的体积的光衰减的光学传感器信号,用于递送治疗的治疗递送模块和被配置为计算第一组织氧合的处理器 在开始递送治疗之前从光学传感器信号进行的测量,在开始递送治疗之后从光学传感器信号计算第二组织氧合测量,比较第一和第二组织氧合测量,并确定递送的治疗是否为 成功地响应于第一次组织氧合测量和第二次组织氧合测量。

    Wireless cardiac pulsatility sensing
    6.
    发明授权
    Wireless cardiac pulsatility sensing 有权
    无线心脏搏动检测

    公开(公告)号:US08244339B2

    公开(公告)日:2012-08-14

    申请号:US12852740

    申请日:2010-08-09

    Abstract: An implantable medical device system and associated method monitor changes in transimpedance in a body tissue due to changes in cardiac pulsatility. A first dipole is used to deliver a non-stimulating electrical current. The first dipole includes a first electrode and a second electrode adapted to be deployed along a first body location. A second dipole is used to measure a voltage resulting from the non-stimulating electrical current being conducted through a portion of a patient's body. The second dipole includes a third electrode and a fourth electrode different than the first electrode and the second electrode and adapted to be deployed along a second body location spaced apart from the first body location.

    Abstract translation: 可植入医疗装置系统和相关方法监测由于心脏搏动的变化而导致的身体组织中的跨阻抗变化。 第一偶极子用于传递非刺激电流。 第一偶极子包括适于沿着第一身体位置展开的第一电极和第二电极。 使用第二偶极子来测量通过患者身体的一部分传导的非刺激性电流产生的电压。 第二偶极子包括不同于第一电极和第二电极的第三电极和第四电极,并且适于沿着与第一主体位置间隔开的第二主体位置展开。

    Tissue Oxygenation Monitoring in Heart Failure
    8.
    发明申请
    Tissue Oxygenation Monitoring in Heart Failure 审中-公开
    心力衰竭组织氧合监测

    公开(公告)号:US20100318146A1

    公开(公告)日:2010-12-16

    申请号:US12797815

    申请日:2010-06-10

    CPC classification number: A61N1/36557

    Abstract: A medical device for monitoring delivery of a therapy that includes a therapy delivery module to deliver a therapy, a controller to set a therapy delivery control parameter, an optical sensor to produce a signal corresponding to tissue light attenuation, and a processor configured to compute a tissue oxygenation measurement from the optical sensor signal, wherein the controller, the optical sensor, and the processor operate cooperatively to determine a setting of the therapy delivery control parameter corresponding to a maximum tissue oxygenation.

    Abstract translation: 一种用于监测治疗递送的医疗装置,其包括用于递送疗法的治疗递送模块,用于设置治疗递送控制参数的控制器,用于产生对应于组织光衰减的信号的光学传感器,以及被配置为计算 来自光学传感器信号的组织氧合测量,其中所述控制器,所述光学传感器和所述处理器协同工作以确定对应于最大组织氧合的所述治疗传递控制参数的设置。

    Tissue Oxygenation Monitoring in Heart Failure
    9.
    发明申请
    Tissue Oxygenation Monitoring in Heart Failure 有权
    心力衰竭组织氧合监测

    公开(公告)号:US20100317942A1

    公开(公告)日:2010-12-16

    申请号:US12797816

    申请日:2010-06-10

    CPC classification number: A61N1/36557

    Abstract: A medical device system and associated method are used for monitoring a heart failure patient. A medical device for monitoring delivery of a therapy includes a sensor sensing an optical sensor signal corresponding to light attenuation by a volume of body tissue of a patient, a therapy delivery module to deliver a therapy, and a processor configured to compute a first tissue oxygenation measurement from the optical sensor signal prior to initiating delivery of the therapy, compute a second tissue oxygenation measurement from the optical sensor signal subsequent to initiating delivery of the therapy, compare the first and the second tissue oxygenation measurements, and determine whether the delivered therapy was successful in response to the first tissue oxygenation measurement and the second tissue oxygenation measurement.

    Abstract translation: 医疗器械系统和相关方法用于监测心力衰竭患者。 用于监测治疗递送的医疗装置包括传感器,其感测对应于患者的身体组织的体积的光衰减的光学传感器信号,用于递送治疗的治疗递送模块和被配置为计算第一组织氧合的处理器 在开始递送治疗之前从光学传感器信号进行的测量,在开始递送治疗之后从光学传感器信号计算第二组织氧合测量,比较第一和第二组织氧合测量,并确定递送的治疗是否为 成功地响应于第一次组织氧合测量和第二次组织氧合测量。

    Device and Method for Monitoring of Absolute Oxygen Saturation and Tissue Hemoglobin Concentration
    10.
    发明申请
    Device and Method for Monitoring of Absolute Oxygen Saturation and Tissue Hemoglobin Concentration 有权
    用于监测绝对氧饱和度和组织血红蛋白浓度的装置和方法

    公开(公告)号:US20100317939A1

    公开(公告)日:2010-12-16

    申请号:US12797770

    申请日:2010-06-10

    Abstract: A method and medical device for detecting signals that detects emitted light scattered by a volume of tissue delivered along a first pathway and a second pathway different from the first pathway, detects emitted light scattered by a volume of tissue delivered along a third pathway and a fourth pathway different from the third pathway, determines a first uniformity corresponding to the emitted light detected along the first pathway and the second pathway, determines a second uniformity corresponding to the emitted light detected along third pathway and the fourth pathway, determines a total uniformity in response to the determined first uniformity and the determined second uniformity, and alters sensing by the device in response to the determined total uniformity.

    Abstract translation: 一种用于检测信号的方法和医疗装置,其检测由沿着第一路径传送的组织体积散射的发射光和不同于第一路径的第二路径的信号,检测由沿着第三路径传送的组织体积散射的发射光, 确定与沿着第一路径和第二路径检测到的发射光相对应的第一均匀度,确定对应于沿着第三路径和第四路径检测的发射光的第二均匀度,确定响应中的总均匀性 到所确定的第一均匀性和确定的第二均匀性,并且改变由所述装置响应于所确定的总均匀性的感测。

Patent Agency Ranking